Background: Allergic diseases seem less prevalent in communities in less developed parts of the world, where parasite infections are highly prevalent. Altogether not much is known about the association between chronic infections with tissue and blood-dwelling parasites and atopy. Methods: In an area in Gabon endemic for blood and tissue parasites, 520 schoolchildren were parasitologically examined and skin prick-tested for a set of common environmental aeroallergens. Levels of allergen-specific IgE and polyclonal IgE were measured. Results: In schoolchildren schistosome and filarial infections increased with age, whereas malaria was more prevalent in younger children. In contrast to allergen sensitization that increased with age, skin test reactivity tended to decline. The number of children with mite-specific IgE antibodies (47%) by far exceeded the number responding to skin prick testing (11%). Mite sensitization was found to be the highest in children infected with schistosomes and/or filariae whereas skin test reactivity was lowest. The multiple logistic regression showed that the risk of a positive skin test was 8-fold higher with increasing levels of mite-specific IgE but was reduced by 72% when infected with blood stage helminths. Conclusions: Chronic blood and tissue parasite infections that are often capable of modulating immune responses in the host are negatively associated with skin test reactivity in a sensitized population.

Keywords:
Atopy, Skin test reactivity, Malaria, Helminth, Schistosomiasis, Filariasis, IgE, Africa
1.
Strachan DP: Hay fever, hygiene, and household size. BMJ 1989;299:1259–1260.
2.
Beasley R, Keil U, von Mutius E, Pearce N: Worldwide variation in prevalence of symptoms of asthma, allergic rhino-conjunctivitis, and atopic eczema: ISAAC. Lancet 1998;351:1225–1232.
3.
Yemaneberhan H, Bekele Z, Venn A, Lewis S, Parry E, Britton J: Prevalence of wheeze and asthma and relation to atopy in urban and rural Ethiopia. Lancet 1997;350:85–90.
4.
Faniran AO, Peat JK, Woolcock AJ: Prevalence of atopy, asthma symptoms and diagnosis and the management of asthma: Comparison of an affluent and a non-affluent country. Thorax 1999;54:606–610.
5.
Shaheen SO, Aaby AJ, Barker DJP, Heyes CB, Shiell AW, Goudiaby A: Measles and atopy in Guinea-Bissau. Lancet 1996;347:1792–1796.
6.
Lynch NR, Hagel I, Perez M, Di Prisco MC, Lopez R, Alvarez N: Effect of anthelmintic treatment on the allergic reactivity of children in a tropical slum. J Allergy Clin Immunol 1993;92:404–411.
7.
Matricardi PM, Rosmini F, Ferrigno L, Nisini R, Rapicetta M, Chionne P, Stroffolini T, Pasquini P, D’Amelio R: Cross-sectional retrospective study of prevalence of atopy among Italian military students with antibodies against hepatitis A virus. BMJ 1997;314:999–1003.
8.
Allen JE, Maizels RM: Immunology of human helminth infection. Int Arch Allergy Immunol 1996;109/1:3–10.
9.
Jakobsen PH, Bate CAW, Taverne J, Playfiar JHL: Malaria: Toxins, cytokines and disease. Parasite Immunol 1995;17/5:223–231.
10.
Mordmuller BG, Metzger WG, Juilllard P, Brinkman BMN, Verweij CL, Grau E, Kremsner PG: Tumor necrosis factor in Plasmodium falciparum malaria: High plasma level is associated with fever, but high production capacity is associated with rapid fever clearance. Eur Cytokine Netw 1997;8/1:29–35.
11.
Kurtzhals JA, Adabayeri V, Goka BQ, Akanmori BD, Oliver-Commey JO, Nkrumah FK, Behr C, Hviid L: Low plasma concentrations of interleukin 10 in severe malarial anaemia compared with cerebral and uncomplicated malaria. Lancet 1998;351:1768–1772.
12.
Sartono E, Kruize YC, Kurniawan A, van der Meide PH, Partono F, Maizels RM, Yazdanbakhsh M: Elevated cellular immune responses and interferon-gamma release after long-term diethylcarbamazine treatment of patients with human lymphatic filariasis. J Infect Dis 1995;171:1683–1687.
13.
Grogan JL, Kremsner PG, Deelder AM, Yazdanbakhsh M: Antigen-specific proliferation and interferon-gamma and interleukin-5 production are down-regulated during Schistosoma haematobium infection. J Infect Dis 1998;177:1433–1437.
14.
Van den Biggelaar AHJ, Van Ree R, Rodrigues LC, Lell B, Deelder AM, Kremsner PG, Yazdanbakhsh M: Reduced atopy in Schistosoma haematobium infected children: A role for parasite-induced IL-10. Lancet 2000;356:1723–1727.
15.
Wildling E, Winkler S, Kremsner PG, Brandts C, Jenne L, Wernsdorfer WH: Malaria epidemiology in the province of Moyen Ogooue, Gabon. Trop Med Parasitol 1995;46/2:77–82.
16.
Katz N, Chaves A, Pellegrino J: A simple device for quantitative stool thick-smear technique in schistosomiasis mansoni. Rev Inst Med Trop Sao Paulo 1972;14:397–400.
17.
Dreborg S, Frew A: Allergen standardisation and skin tests. EAACI position paper. Allergy 1993;48(S14):49–82.
18.
Terhell AJ, Haarbrink M, Abadi K, Bronneberg DC, Tieleman MC, Asri M, Yazdanbakhsh M: A filter paper technique for the detection of anti-filarial IgG4 in lymphatic filariasis. Trans R Soc Trop Med Hyg 1996;90/2:196–198.
19.
Aalberse RC, Koshte V, Clemens JG: Immunoglobulin E antibodies that cross-react with vegetable foods, pollen, and Hymenoptera venom. J Allergy Clin Immunol 1981;68:356–364.
20.
Schuurman J, Perdok GJ, Lourens TE, Parren PW, Chapman MD, Aalberse RC: Production of a mouse/human chimeric IgE monoclonal antibody to the house dust mite allergen Der p 2 and its use for the absolute quantification of allergen-specific IgE. J Allergy Clin Immunol 1997;99:545–550.
21.
Van Ree R, van Leeuwen WA, van den Berg M, Weller HH, Aalberse RC: IgE and IgG cross-reactivity among Lol p I and Lol p II/III. Identification of the C-termini of Lol p I, II, and III as cross-reactive structures. Allergy 1994;49:254–261.
22.
Witteman AM, Akkerdaas JH, van Leeuwen J, van der Zee JS, Aalberse RC: Identification of a cross-reactive allergen (presumably tropomyosin) in shrimp, mite and insects. Int Arch Allergy Immunol 1994;105/1:56–61.
23.
Addo Yobo EO, Custovic A, Taggart SC, Asafo-Agyei AP, Woodcock A: Exercise induced bronchospasm in Ghana: Differences in prevalence between urban and rural schoolchildren. Thorax 1997;52/2:161–165.
24.
Selassie FG, Stevens RH, Cullinan P, Pritchard D, Jones M, Harris J, Ayres JG, Newman Taylor AJ: Total and specific IgE (house dust mite and intestinal helminths) in asthmatics and controls from Gondar, Ethiopia. Clin Exp Allergy 2000;30:356–358.
25.
Hagel I, Lynch NR, Perez M, Di Prisco MC, Lopez R, Rojas E: Modulation of the allergic reactivity of slum children by helminthic infection. Parasite Immunol 1993;15:311–315.
26.
King CL, Poindexter RW, Ragunathan J, Fleisher TA, Ottesen EA, Nutman TB: Frequency analysis of IgE-secreting B lymphocytes in persons with normal or elevated serum IgE levels. J Immunol 1991;146:1478–1483.
27.
Thomas WR, Smith W: Towards defining the full spectrum of important house dust mite allergens. Clin Exp Allergy 1999;29:1583–1587.
28.
Godfrey RC, Gradidge CF: Allergic sensitisation of human lung fragments prevented by saturation of IgE binding sites. Nature 1976;259:484–486.
29.
Pritchard DI: Immunity to helminths: Is too much IgE parasite- rather than host-protective? Parasite Immunol 1993;15/1:5–9.
30.
Shirakawa T, Enomoto T, Shimazu S, Hopkin JM: The inverse association between tuberculin responses and atopic disorder. Science 1997;275:77–79.
31.
Cookson WO, Moffatt MF: Asthma: An epidemic in the absence of infection? Science 1997;275:41–42.
32.
Holgate ST: The epidemic of allergy and asthma. Nature 1999;402(suppl):B2–4.
33.
Yazdanbakhsh M, Sartono E, Kruize YC, Kurniawan A, van der Pouw-Kraan T, van der Meide PH, Selkirk ME, Partono F, Hintzen RQ, Van Lier RAW, Maizels RM: Elevated levels of T cell activation antigen CD27 and increased interleukin-4 production in human lymphatic filariasis. Eur J Immunol 1993;23:3312–3317.
© 2001 S. Karger AG, Basel
2001
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.